In an Extraordinary Year, Vertex Continues Its Unwavering Commitment to Corporate Responsibility; Announces 2021 CR Report


2021 was an important year for Vertex and one that positioned the company well for the future as they continued to discover, develop and commercialize transformative medicines for people with serious diseases while demonstrating an unwavering commitment to corporate responsibility.

In a Remarkable Year, Vertex Fuels Its Efforts in Corporate Responsibility; Announces 2020 CR Report


The COVID-19 pandemic and a heightened focus on social and racial justice brought about unprecedented disruption, change and uncertainty. Yet during such a time, Vertex remained steadfast in its mission to innovate and deliver transformative medicines and remained equally committed to supporting its talented workforce and communities.   

Subscribe to Vertex